BPC-157 research overview — the analytical context
A documented overview of BPC-157 (Body Protection Compound) — sequence, stability profile, common analytical specifications, and the research literature most frequently cited in vendor materials.
[DRAFT — titan-copy to expand]
BPC-157, short for Body Protection Compound 157, is a synthetic pentadecapeptide derived from a partial sequence of a gastric protein. It is one of the most frequently cited research peptides in the post-2010 literature, and is also one of the most frequently misrepresented in vendor marketing copy.
This overview limits itself to what the analytical record can actually establish: the molecule's structure, the specifications a credible lot should meet, and the conditions under which the material remains stable.
Sequence and physical properties
BPC-157 is a 15-residue peptide with the sequence GEPPPGKPADDAGLV. Its monoisotopic mass is approximately 1419.5 Da. The peptide is freely soluble in water and bacteriostatic water across a wide pH range and presents as a white-to-off-white lyophilized powder when properly handled.
Common analytical specifications
Research-grade BPC-157 is typically released against a documented specification of greater than 98% HPLC purity at 220 nm, with mass-spectrometric confirmation of the target mass and a per-lot endotoxin limit established by LAL. Vendors who supply the compound for research applications without publishing a chromatogram, a mass spectrum, and an LAL value are not supplying a documented lot — they are supplying a labeled vial.
Stability and reconstitution
Lyophilized BPC-157 is stable for extended periods at minus twenty degrees Celsius. Once reconstituted in bacteriostatic water, the material is generally considered stable for several weeks under refrigeration, with degradation kinetics dependent on pH, temperature, and the presence of preservative. Detailed reconstitution and handling guidance lives on the protocols page; this overview is a research-context document, not a use-instruction.
Research literature
The peer-reviewed corpus on BPC-157 is dominated by rodent studies, with a smaller number of in-vitro mechanistic papers. Topics include tissue repair models, vascular response, and gastrointestinal-tract experiments. None of the literature establishes safety or efficacy in humans, and the compound is not approved for human use in any jurisdiction.
References
The PubMed index for BPC-157 contains an extensive body of peer-reviewed work. Primary literature is searchable via NCBI:
- BPC-157 research corpus — PubMed / NCBI
- BPC-157 gastrointestinal and vascular models — PubMed search
All citations above link to the U.S. National Library of Medicine's PubMed database. Lumin Research is not affiliated with any of the cited research institutions. Published findings in animal or cell-line models do not constitute evidence of safety or efficacy in humans.